参考文献/References:
[1] Yang Y,Zhou L,Gou X,et al.Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer[J].Math Biosci Eng,2022,19(1):595-611.
[2] Zhao JJ,Liu JJ,Zhang YY,et al.SNHG16 lncRNAs are overexpressed and may be oncogenic in human gastric cancer by regulating cell cycle progression[J].Neoplasma,2022,69(1):49-58.
[3] Gao SS,Zhang ZK,Wang XB,et al.Role of transcribed ultraconserved regions in gastric cancer and therapeutic perspectives[J].World J Gastroenterol,2022,28(25):2900-2909.
[4] 刘宗义,朱付平,李武平.桃红四物汤对大鼠肢体缺血-再灌注损伤骨骼肌长链非编码RNA H19、核因子κB-p65表达的影响[J].陕西中医,2022,43(9):1163-1169.
[5] Wang G,Zhang Z,Xia C.Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis[J].Bioengineered,2021,12(2):9678-9691.
[6] 杜 森,赵 森,周 青,等.血清长链非编码RNA小核仁RNA宿主基因3检测联合核磁共振弥散加权成像在乳腺癌诊断中的应用[J].陕西医学杂志,2022,51(8):1021-1024.
[7] Gao L,Xue J,Liu X,et al.A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients[J].Aging(Albany NY),2021,13(23):25453-25465.
[8] 卓少华,丘远聪,郑俊德,等.人参皂苷Rg5调控lncRNA-PCAT12抑制胃癌细胞生长实验研究[J].陕西中医,2020,41(4):437-439.
[9] Li T,Zhang X,Cheng L,et al.Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress[J].J Cell Mol Med,2022,26(8):2205-2217.
[10] Huang C,Liu J,He L,et al.The long noncoding RNA noncoding RNA activated by DNA damage(NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development[J].Bioengineered,2021,12(2):11738-11755.
[11] Kong W,Yin G,Zheng S,et al.Long non-coding RNA(lncRNA)HOTAIR:Pathogenic roles and therapeutic opportunities in gastric cancer[J].Genes Dis,2022,9(5):1269-1280.
[12] Li Z,Liu X,Luo N,et al.Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer[J].Bioengineered,2021,12(2):12931-12939.
[13] Chen WM,Chen YM,Jiang SY,et al.LncRNA POT1-AS1 accelerates the progression of gastric cancer by serving as a competing endogenous RNA of microRNA-497-5p to increase PDK3 expression[J].J Gastrointest Oncol,2021,12(6):2728-2742.
[14] Xie Y,Rong L,He M,et al.LncRNA SNHG3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-139-5p/MYB axis[J].Aging(Albany NY),2021,13(23):25138-25152.
[15] 高 宾,王春花,李雅琪,等.长链非编码RNA在口腔鳞状细胞癌及其微环境中的作用研究进展[J].陕西医学杂志,2022,51(11):1458-1461.
[16] Zhang J,Liu X,Chen J,et al.HDAC3-mediated repression of lncRNA-LET regulates gastric cancer cell growth proliferation,invasion,migration,and apoptosis via miR-548k[J].J Environ Pathol Toxicol Oncol,2021,40(4):21-32.
[17] Fan B,Jiao BH,Fan FS,et al.Downregulation of miR-95-3p inhibits proliferation,and invasion promoting apoptosis of glioma cells by targeting CELF2[J].Int J Oncol,2015,47(3):1025-1033.
[18] Xi M,Cheng L,Hua W,et al.MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway[J].Eur Rev Med Pharmacol Sci,2019,23(3):1002-1011.
[19] Chen Z,Gong X,Cheng C,et al.Circ_0001777 affects triple-negative breast cancer progression through the miR-95-3p/AKAP12 axis[J].Clin Breast Cancer,2023,23(2):143-154.
[20] Ni Q,Zhang Y,Tao R,et al.MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling[J].Aging(Albany NY),2021,13(6):8665-8687.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(6):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(6):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(6):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(6):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(6):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(6):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(6):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]